Publisher's Note. Myriad innovations in bladder cancer.
| Publicado en: | Urology Times Vol. 52; no. 3; p. 15 |
|---|---|
| Autor principal: | |
| Formato: | editorial Journal Article |
| Publicado: |
MJH Life Sciences
Mar2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175979578&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 175979578 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00939722 URO jtl: Urology Times issn: 00939722 maglogo: N pubinfo: dt: Mar2024 vid: 52 iid: 3 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 175979578 175979578 175979578 175979578 ppf: 15 ppct: 0 formats: fmt: @attributes: type: P tig: atl: Publisher's Note. Myriad innovations in bladder cancer. aug: au: HENNESSY JR, MIKE affil: President and CEO of Urology Times' parent company, MJH Life Sciences® sug: subj: Diffusion of Innovation Bladder Neoplasms Serial Publications pubtype: Academic Journal doctype: editorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|